To view this email as a web page, click here.
 
FDA warns CBD supplement maker
While FDA approved the first drug containing cannibidiol (CBD), it is cracking down on certain other CBD products marketed as supplements.
Read more
 
Top 3 new drugs to treat rare diseases
FDA recently approved a new treatment for 2 rare types of non-Hodgkin lymphomas, as well as a new drug to treat hereditary angiodema and 1 for Fabry disease.
Read more
 
Generic EpiPen poised to alleviate shortages
FDA approved the first generic version of epinephrine (EpiPen and EpiPen Jr), which may help alleviate the current shortage of EpiPen in certain areas of the United States.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.